Old and new inotropic drugs
- PMID: 6144152
- DOI: 10.1016/0300-9572(84)90019-4
Old and new inotropic drugs
Abstract
An ideal cardiotonic agent should improve cardiac contractility and increase the oxygen supply to various tissues without inducing tachycardia, arrhythmias, decrease in coronary blood flow or increment in oxygen requirements of the myocardium. It should also be safe and orally active and have a persistent action. The aim of this paper is to describe various positive inotropic drugs at our disposal. The hemodynamic effects and the indications of adrenaline, noradrenaline, isoprenaline, dopamine, dobutamine and cardiac glycosides are presented first. Then several new promising orally active compounds are discussed.
Similar articles
-
Inotropic drugs and their mechanisms of action.J Am Coll Cardiol. 1984 Aug;4(2):389-97. doi: 10.1016/s0735-1097(84)80231-4. J Am Coll Cardiol. 1984. PMID: 6330195 Review.
-
[New cardiotonic agents].Ann Cardiol Angeiol (Paris). 1985 Dec;34(10):681-8. Ann Cardiol Angeiol (Paris). 1985. PMID: 2936298 French.
-
Inotropic and vasopressor agents.Br J Anaesth. 1984 Jul;56(7):767-80. doi: 10.1093/bja/56.7.767. Br J Anaesth. 1984. PMID: 6375707 Review. No abstract available.
-
[New drugs with positive inotropic action].Kardiol Pol. 1982;25(4):357-65. Kardiol Pol. 1982. PMID: 6128439 Review. Polish. No abstract available.
-
Inotropic drugs of the future.Eur J Clin Invest. 1982 Dec;12(6):441-3. doi: 10.1111/j.1365-2362.1982.tb02221.x. Eur J Clin Invest. 1982. PMID: 6217976 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources